Trinity Biotech Plc (TRIB)
5.69
-0.63
(-9.97%)
USD |
NASDAQ |
Oct 02, 16:00
5.46
-0.23
(-4.04%)
After-Hours: 20:00
Trinity Biotech Enterprise Value : 136.51M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 136.51M |
| October 01, 2026 | 136.92M |
| September 30, 2026 | 136.99M |
| September 29, 2026 | 137.16M |
| September 28, 2026 | 137.18M |
| September 25, 2026 | 137.20M |
| September 24, 2026 | 137.32M |
| September 23, 2026 | 137.36M |
| September 22, 2026 | 137.62M |
| September 21, 2026 | 137.58M |
| September 18, 2026 | 137.51M |
| September 17, 2026 | 137.53M |
| September 16, 2026 | 137.38M |
| September 15, 2026 | 137.57M |
| September 14, 2026 | 137.66M |
| September 11, 2026 | 137.83M |
| September 10, 2026 | 137.87M |
| September 09, 2026 | 138.00M |
| September 08, 2026 | 138.69M |
| September 04, 2026 | 138.91M |
| September 03, 2026 | 139.03M |
| September 02, 2026 | 139.03M |
| September 01, 2026 | 139.11M |
| August 31, 2026 | 139.21M |
| August 28, 2026 | 139.08M |
| Date | Value |
|---|---|
| August 27, 2026 | 139.13M |
| August 26, 2026 | 139.03M |
| August 25, 2026 | 139.10M |
| August 24, 2026 | 139.50M |
| August 21, 2026 | 139.68M |
| August 20, 2026 | 139.65M |
| August 19, 2026 | 139.94M |
| August 18, 2026 | 140.86M |
| August 17, 2026 | 140.05M |
| August 14, 2026 | 140.37M |
| August 13, 2026 | 140.50M |
| August 12, 2026 | 140.35M |
| August 11, 2026 | 141.47M |
| August 10, 2026 | 141.35M |
| August 07, 2026 | 140.86M |
| August 06, 2026 | 140.35M |
| August 05, 2026 | 139.79M |
| August 04, 2026 | 139.94M |
| August 03, 2026 | 140.02M |
| July 31, 2026 | 140.32M |
| July 30, 2026 | 141.06M |
| July 29, 2026 | 141.34M |
| July 28, 2026 | 140.87M |
| July 27, 2026 | 138.74M |
| July 24, 2026 | 138.29M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DBV Technologies SA | 411.48M |
| Cellectis SA | 81.43M |
| Akari Therapeutics Plc | 8.202M |
| Autolus Therapeutics Plc | 638.46M |
| Evaxion AS | 19.79M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.416M |
| Revenue (Quarterly) | 10.84M |
| Total Expenses (Quarterly) | 15.26M |
| EPS Diluted (Quarterly) | -6.853 |
| Profit Margin (Quarterly) | -40.74% |
| Earnings Yield | -930.2% |